Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1

Oncogene. 2004 Mar 4;23(9):1656-67. doi: 10.1038/sj.onc.1207064.

Abstract

In cultured human dermal fibroblasts, transforming growth factor (TGF)-beta induced the mRNA expression of tenascin-C (TN-C). The molecular mechanism(s) underlying this process is not presently understood. In this study, we performed serial 5' deletion and a transient transfection analysis to define a region in the TN-C promoter mediating the inducible responsiveness to TGF-beta. This region contains an atypical nucleotide recognition element for the Smad family of transcriptional regulators. A DNA affinity precipitation assay revealed that Smad2/Smad3 bound to this site in a transient and specific manner. Overexpression of Smad3 or Smad4 activated the TN-C promoter activity and superinduced the TN-C promoter activity stimulated by TGF-beta. Moreover, simultaneous cotransfection of Smad3 and Smad4 activated the TN-C promoter activity in a synergistic manner. Mutation of the Smad-binding sites, the Ets-binding sites, or Sp1/3-binding sites in the TN-C promoter abrogated the TGF-beta/Smad-inducible promoter activity. Immunoprecipitation analysis revealed that Smad3, Sp1, and Ets1 form a transcriptionally active complex. Furthermore, the interaction between Smads and CBP/p300 in TGF-beta signaling was confirmed. These findings demonstrate the existence of a novel, functional binding element in the proximal region of the TN-C promoter mediating responsiveness to TGF-beta involving Smad3/4, Sp1, Ets1, and CBP/p300.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Cells, Cultured
  • DNA-Binding Proteins / metabolism*
  • Dermis / cytology
  • Dermis / drug effects
  • Dermis / metabolism
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Humans
  • Molecular Sequence Data
  • Mutation / genetics
  • Nuclear Proteins / metabolism
  • Plicamycin / pharmacology
  • Promoter Regions, Genetic / genetics
  • Protein Binding
  • Proto-Oncogene Protein c-ets-1
  • Proto-Oncogene Proteins / metabolism*
  • Proto-Oncogene Proteins c-ets
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Response Elements / genetics
  • Signal Transduction / drug effects
  • Smad3 Protein
  • Smad4 Protein
  • Sp1 Transcription Factor / metabolism*
  • Tenascin / genetics*
  • Trans-Activators / metabolism*
  • Transcription Factors / metabolism*
  • Transforming Growth Factor beta / pharmacology*
  • Up-Regulation / drug effects*

Substances

  • DNA-Binding Proteins
  • ETS1 protein, human
  • Nuclear Proteins
  • Proto-Oncogene Protein c-ets-1
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-ets
  • RNA, Messenger
  • SMAD3 protein, human
  • SMAD4 protein, human
  • Smad3 Protein
  • Smad4 Protein
  • Sp1 Transcription Factor
  • Tenascin
  • Trans-Activators
  • Transcription Factors
  • Transforming Growth Factor beta
  • Plicamycin